Robert Holloway, MD

Title(s)Clinical Associate Professor of Psychiatry & the Behavioral Sciences, Pediatrics, and Anesthesiology (Clinician Educator)
SchoolKeck School of Medicine of Usc
AddressCHLA 4650 W. Sunset Blvd.
Off Campus
Los Angeles CA 90026
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease: Baseline Results. Neurol Genet. 2022 Oct; 8(5):e200008. Jensen-Roberts S, Myers TL, Auinger P, Cannon P, Rowbotham HM, Coker D, Chanoff E, Soto J, Pawlik M, Amodeo K, Sharma S, Valdovinos B, Wilson R, Sarkar A, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Holloway RG, Dorsey ER, Schneider RB. PMID: 35966918; PMCID: PMC9372873.
      View in: PubMed   Mentions: 2  
    2. A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design. J Parkinsons Dis. 2020; 10(3):1195-1207. Schneider RB, Myers TL, Rowbotham HM, Luff MK, Amodeo K, Sharma S, Wilson R, Jensen-Roberts S, Auinger P, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Cannon P, 23andMe Research Team, Holloway RG, Dorsey ER. PMID: 32568109; PMCID: PMC7505001.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    3. The lack of documentation of preferences in a cohort of adults who died after ischemic stroke. Neurology. 2016 05 31; 86(22):2056-62. Robinson MT, Vickrey BG, Holloway RG, Chong K, Williams LS, Brook RH, Leng M, Parikh P, Zingmond DS. PMID: 27060165; PMCID: PMC4891211.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    4. Neurologists as primary palliative care providers: Communication and practice approaches. Neurol Clin Pract. 2016 Feb; 6(1):40-48. Creutzfeldt CJ, Robinson MT, Holloway RG. PMID: 26918202; PMCID: PMC4753829.
      View in: PubMed   Mentions: 34  
    5. Cost of deep brain stimulation for the treatment of Parkinson's disease by surgical stimulation sites. Mov Disord. 2014 Nov; 29(13):1666-74. Stroupe KT, Weaver FM, Cao L, Ippolito D, Barton BR, Burnett-Zeigler IE, Holloway RG, Vickrey BG, Simuni T, Follett KA. PMID: 25220042.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    6. Racial/Ethnic differences in process of care and outcomes among patients hospitalized with intracerebral hemorrhage. Stroke. 2014 Nov; 45(11):3243-50. Xian Y, Holloway RG, Smith EE, Schwamm LH, Reeves MJ, Bhatt DL, Schulte PJ, Cox M, Olson DM, Hernandez AF, Lytle BL, Anstrom KJ, Fonarow GC, Peterson ED. PMID: 25213344.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    7. Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease. Mov Disord. 2014 Feb; 29(2):169-76. Dodel R, Jönsson B, Reese JP, Winter Y, Martinez-Martin P, Holloway R, Sampaio C, Ružicka E, Hawthorne G, Oertel W, Poewe W, Stebbins G, Rascol O, Goetz CG, Schrag A. PMID: 23861335.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    8. Parkinson's disease medication use and costs following deep brain stimulation. Mov Disord. 2012 Sep 15; 27(11):1398-403. Weaver FM, Stroupe KT, Cao L, Holloway RG, Vickrey BG, Simuni T, Hendricks A, Ippolito D. PMID: 22975928.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    9. Sham surgery controls in Parkinson's disease clinical trials: views of participants. Mov Disord. 2012 Sep 15; 27(11):1461-5. Kim SY, De Vries R, Holloway RG, Wilson R, Parnami S, Kim HM, Frank S, Kieburtz K. PMID: 22927064; PMCID: PMC3703438.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    10. Comparison of enrollees and decliners of Parkinson disease sham surgery trials. Mov Disord. 2012 Apr; 27(4):506-11. Kim SY, Wilson RM, Kim HM, Holloway RG, De Vries RG, Frank SA, Kieburtz K. PMID: 22314796; PMCID: PMC3323770.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    11. Patient and organizational factors related to education and support use by Veterans with Parkinson's disease. Mov Disord. 2009 Oct 15; 24(13):1916-24. Pogoda TK, Cramer IE, Meterko M, Lin H, Hendricks A, Holloway RG, Charns MP. PMID: 19606487.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    12. Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model. J Womens Health (Larchmt). 2009 Sep; 18(9):1355-60. Yurcheshen ME, Guttuso T, McDermott M, Holloway RG, Perlis M. PMID: 19708803.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    13. Funding of Parkinson research from industry and US federal and foundation sources. Mov Disord. 2009 Apr 15; 24(5):731-7. Dorsey ER, Thompson JP, Frasier M, Sherer T, Fiske B, Nicholson S, Johnston SC, Holloway RG, Moses H. PMID: 19133662.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    14. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15; 23(15):2129-70. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N, Movement Disorder Society UPDRS Revision Task Force. PMID: 19025984.
      View in: PubMed   Mentions: 2256     Fields:    Translation:Humans
    15. Ethics of sham surgery: perspective of patients. Mov Disord. 2008 Jan; 23(1):63-8. Frank SA, Wilson R, Holloway RG, Zimmerman C, Peterson DR, Kieburtz K, Kim SY. PMID: 17960809.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    16. Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology. 2007 Jul 10; 69(2):187-95. Biglan KM, Holloway RG, McDermott MP, Richard IH, Parkinson Study Group CALM-PD Investigators. PMID: 17620552.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    17. Health care costs decline after successful epilepsy surgery. Neurology. 2007 Apr 17; 68(16):1290-8. Langfitt JT, Holloway RG, McDermott MP, Messing S, Sarosky K, Berg AT, Spencer SS, Vickrey BG, Sperling MR, Bazil CW, Shinnar S. PMID: 17438219.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    18. Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey. Mov Disord. 2007 Mar 15; 22(4):509-14. Noyes K, Liu H, Holloway R, Dick AW. PMID: 17230477.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    19. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord. 2007 Jan; 22(1):41-7. Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N. PMID: 17115387.
      View in: PubMed   Mentions: 503     Fields:    Translation:Humans
    20. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries. Mov Disord. 2006 Mar; 21(3):362-72. Noyes K, Liu H, Li Y, Holloway R, Dick AW. PMID: 16211621.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    21. Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life. Value Health. 2006 Jan-Feb; 9(1):28-38. Noyes K, Dick AW, Holloway RG, Parkinson Study Group. PMID: 16441522.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    22. Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trial. Med Decis Making. 2004 Sep-Oct; 24(5):472-85. Noyes K, Dick AW, Holloway RG, Parkinson Study Group. PMID: 15358996.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    23. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004 Sep; 19(9):1020-8. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L, Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. PMID: 15372591.
      View in: PubMed   Mentions: 762     Fields:    
    24. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol. 2004 Jul; 61(7):1044-53. Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A, Parkinson Study Group. PMID: 15262734.
      View in: PubMed   Mentions: 159     Fields:    Translation:HumansCTClinical Trials
    25. Development and testing of the Parkinson's disease quality of life scale. Mov Disord. 2003 Jun; 18(6):637-45. Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J, Parkinson Study Group. PMID: 12784266.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    26. Neurologists' use of ICD-9CM codes for dementia. Neurology. 2001 May 08; 56(9):1206-9. Pippenger M, Holloway RG, Vickrey BG. PMID: 11342688.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    27. Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions. Mov Disord. 2000 May; 15(3):439-45. Siderowf AD, Holloway RG, Stern MB. PMID: 10830407.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    28. Carotid endarterectomy trends in the patterns and outcomes of care at academic medical centers, 1990 through 1995. Arch Neurol. 1998 Jan; 55(1):25-32. Holloway RG, Witter DM, Mushlin AI, Lawton KB, McDermott MP, Samsa GP. PMID: 9443708.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Robert's Networks
    Concepts (148)
    Derived automatically from this person's publications.
    Co-Authors (3)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department